I

IMV Inc.

160 employees

IMV is a clinical-stage immuno-oncology company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cancer
Immuno-Oncology
DPX Platform
solid cancer
breast cancer
Health Care
Oncology
Ovarian Cancer
immunotherapy
DLBCL
bladder cancer

Date founded

2000

Funding rounds raised

Total raised

$25M

from 1 investors over 1 rounds

I

IMV Inc. raised $25M on May 18, 2020

Investors: Lumira Ventures

FAQ